Avient Corp

In a Stage 4 decline with price failing key support at ~41.41 and trading below the 9- and 20-day EMAs, the medium-term bias is bearish. Short-term momentum remains negative with EMAs declining and no oversold exhaustion evident. Execution favors selling into any rallies toward the 20-EMA/50-SMA zone (~42.50–42.80). A break below 41.41 on increased volume would confirm further acceleration of downside.

• ↑FY23 revenue $30.2M (+33% YoY); Adjusted EBITDA $4.4M (+132% YoY).
• ↑Q3 production 3,268 kg (+61% YoY) after Flower Group integration.
• ↓Recreational sales decline noted by management could hinder revenue momentum.